Found: 162
Select item for more details and to access through your institution.
The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum.
- Published in:
- Diabetes Care, 2024, v. 47, n. 9, p. 1491, doi. 10.2337/dci24-0052
- By:
- Publication type:
- Article
Do sex differences in paediatric type 1 diabetes care exist? A systematic review.
- Published in:
- Diabetologia, 2023, v. 66, n. 4, p. 618, doi. 10.1007/s00125-022-05866-4
- By:
- Publication type:
- Article
Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes.
- Published in:
- Diabetologia, 2022, v. 65, n. 10, p. 1721, doi. 10.1007/s00125-022-05750-1
- By:
- Publication type:
- Article
Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Gender gaps in type 1 diabetes care.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 3, p. 425, doi. 10.1007/s00592-022-02023-6
- By:
- Publication type:
- Article
National diabetes registries: do they make a difference?
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 3, p. 267, doi. 10.1007/s00592-020-01576-8
- By:
- Publication type:
- Article
Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 19, p. 3091, doi. 10.3390/cells11193091
- By:
- Publication type:
- Article
Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 2950, doi. 10.3390/cells10112950
- By:
- Publication type:
- Article
Does size matter? Hospital volume and resource use in paediatric diabetes care.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 5, p. 1, doi. 10.1111/dme.15260
- By:
- Publication type:
- Article
Biomechanical and musculoskeletal changes after flexor tenotomy to reduce the risk of diabetic neuropathic toe ulcer recurrence.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 4, p. 1, doi. 10.1111/dme.14761
- By:
- Publication type:
- Article
Gut Microbiota Composition Is Related to AD Pathology.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.794519
- By:
- Publication type:
- Article
Socio‐economic disparities in hospital care among Dutch patients with diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1386, doi. 10.1111/dom.15440
- By:
- Publication type:
- Article
Use of hospital care among Dutch diabetes patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2268, doi. 10.1111/dom.15105
- By:
- Publication type:
- Article
Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1588, doi. 10.1111/dom.14732
- By:
- Publication type:
- Article
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1851, doi. 10.1111/dom.14410
- By:
- Publication type:
- Article
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 988, doi. 10.1111/dom.13990
- By:
- Publication type:
- Article
Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, p. 24, doi. 10.1111/dom.13692
- By:
- Publication type:
- Article
Iloprost infusion prevents the insulin‐induced reduction in skeletal muscle microvascular blood volume but does not enhance peripheral glucose uptake in type 2 diabetic patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2523, doi. 10.1111/dom.13410
- By:
- Publication type:
- Article
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1217, doi. 10.1111/dom.12748
- By:
- Publication type:
- Article
Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41329-z
- By:
- Publication type:
- Article
Gut microbiome-wide association study of depressive symptoms.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34502-3
- By:
- Publication type:
- Article
The gut microbiota and depressive symptoms across ethnic groups.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34504-1
- By:
- Publication type:
- Article
Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis.
- Published in:
- Nutrients, 2023, v. 15, n. 21, p. 4625, doi. 10.3390/nu15214625
- By:
- Publication type:
- Article
The Effect of Dietary Advice Aimed at Increasing Protein Intake on Oral Health and Oral Microbiota in Older Adults: A Randomized Controlled Trial.
- Published in:
- Nutrients, 2023, v. 15, n. 21, p. 4567, doi. 10.3390/nu15214567
- By:
- Publication type:
- Article
Personalized Dietary Advice to Increase Protein Intake in Older Adults Does Not Affect the Gut Microbiota, Appetite or Central Processing of Food Stimuli in Community-Dwelling Older Adults: A Six-Month Randomized Controlled Trial.
- Published in:
- Nutrients, 2023, v. 15, n. 2, p. 332, doi. 10.3390/nu15020332
- By:
- Publication type:
- Article
The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets.
- Published in:
- Nutrients, 2022, v. 14, n. 1, p. 191, doi. 10.3390/nu14010191
- By:
- Publication type:
- Article
Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area.
- Published in:
- Nutrients, 2021, v. 13, n. 9, p. 3289, doi. 10.3390/nu13093289
- By:
- Publication type:
- Article
Protein Intake, Metabolic Status and the Gut Microbiota in Different Ethnicities: Results from Two Independent Cohorts.
- Published in:
- Nutrients, 2021, v. 13, n. 9, p. 3159, doi. 10.3390/nu13093159
- By:
- Publication type:
- Article
Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans.
- Published in:
- Nutrients, 2021, v. 13, n. 8, p. 2706, doi. 10.3390/nu13082706
- By:
- Publication type:
- Article
Gut Microbiota in Hypertension and Atherosclerosis: A Review.
- Published in:
- Nutrients, 2020, v. 12, n. 10, p. 2982, doi. 10.3390/nu12102982
- By:
- Publication type:
- Article
Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition.
- Published in:
- Nutrients, 2020, v. 12, n. 8, p. 2308, doi. 10.3390/nu12082308
- By:
- Publication type:
- Article
Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review.
- Published in:
- Nutrients, 2019, v. 11, n. 12, p. 3000, doi. 10.3390/nu11123000
- By:
- Publication type:
- Article
Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0205858
- By:
- Publication type:
- Article
Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188475
- By:
- Publication type:
- Article
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820941745
- By:
- Publication type:
- Article
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820941745
- By:
- Publication type:
- Article
Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation.
- Published in:
- Therapeutic Advances in Gastroenterology, 2017, v. 10, n. 4, p. 373, doi. 10.1177/1756283X17690480
- By:
- Publication type:
- Article
Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose–response effects on glucose metabolism in human subjects with metabolic syndrome.
- Published in:
- NPJ Biofilms & Microbiomes, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41522-020-0127-0
- By:
- Publication type:
- Article
Effect of Prior Antibiotic Use on Culture Results in People with Diabetes and Foot Osteomyelitis.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 684, doi. 10.3390/antibiotics12040684
- By:
- Publication type:
- Article
Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.942495
- By:
- Publication type:
- Article
Intestinal permeability is associated with aggravated inflammation and myofibroblast accumulation in Graves’ orbitopathy: the MicroGO study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1173481
- By:
- Publication type:
- Article
Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 556, p. 1, doi. 10.1126/scitranslmed.aaz8926
- By:
- Publication type:
- Article
Gut microbiota and metabolites in the pathogenesis of endocrine disease.
- Published in:
- Biochemical Society Transactions, 2020, v. 48, n. 3, p. 915, doi. 10.1042/BST20190686
- By:
- Publication type:
- Article
The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum.
- Published in:
- Diabetes, 2024, v. 73, n. 9, p. 1391, doi. 10.2337/dbi24-0028
- By:
- Publication type:
- Article
Disentangling Genetic Risks for Metabolic Syndrome.
- Published in:
- Diabetes, 2022, v. 71, n. 11, p. 2447, doi. 10.2337/db22-0478
- By:
- Publication type:
- Article
121-LB: Durable Glycemic Improvements after Duodenal Mucosal Resurfacing (DMR) in Patients with Type 2 Diabetes (T2D): 48-Week Results from the REVITA-2 European Cohort.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-121-LB
- By:
- Publication type:
- Article
1156-P: Duodenal Mucosal Resurfacing (DMR) Combined with GLP-1 RA May Eliminate Insulin Therapy and Improve Metabolic Health in Type 2 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1156-P
- By:
- Publication type:
- Article
250-OR: Beta-Cell Rest Induced by Dapagliflozin Improves ß-Cell Secretory Capacity in Type 2 Diabetes Patients: A Randomized Controlled Trial vs. Gliclazide.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-250-OR
- By:
- Publication type:
- Article
243-OR: ADA Presidents' Select Abstract: Dapagliflozin Reduces Measured GFR by Reducing Renal Efferent Arteriolar Resistance in Type 2 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-243-OR
- By:
- Publication type:
- Article